Trial data support 2 regimens for seasonal malaria prevention in Ugandan children
Dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine combined with amodiaquine reduced malaria incidence by 94% and 96%, respectively, compared with a control group.